Before prescribing this medication, healthcare professionals are encouraged to understand the guidelines the patient must follow
Nano TransMed
Its a targeted, scalable solution for weight and metabolic health, built to plug into what your company already provides
Effects of low carbohydrate vs low fat ketogenic diet on appetite and hunger hormones
The analysis found that patients taking tirzepatide were significantly more likely to achieve weight loss: Those taking tirzepatide were 1.8 times more likely than those taking semaglutide to achieve 5% weight loss, 2.5 times more likely than those taking semaglutide to achieve 10% weight loss, And 3.2 times more likely than those taking semaglutide to achieve 15% weight loss
Injectable semaglutide, sold by Novo Nordisk under the brand name Wegovy for weight loss, and tirzepatide, sold by Eli Lily as Zepbound for weight loss, generally cap out at a 15-20% body weight loss for the highest doses and 5-10% on the lower end